Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
425,680
-
Share change
-
0
-
Total reported value
-
$74,560
-
Price per share
-
$0.18
-
Number of holders
-
5
Institutional Holders of ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP) as of Q3 2016
As of 30 Sep 2016,
ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
425,680 shares.
The largest 5 holders included
Geneva Advisors, LLC, FISHMAN JAY A LTD/MI, Sargent Bickham Lagudis LLC, Personal Capital Advisors Corp, and HALLMARK CAPITAL MANAGEMENT INC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.